Transition metal compounds as cancer radiosensitizers
The concomitant administration of ionising radiation (IR) in the form of external beam radiotherapy or targeted radionuclide therapy (TRT) alongside radiosensitizing small molecules is a highly successful strategy for the treatment of cancer. The major clinical impact of the radiosensitizing platinu...
Huvudupphovsmän: | Gill, M, Vallis, K |
---|---|
Materialtyp: | Journal article |
Publicerad: |
Royal Society of Chemistry
2018
|
Liknande verk
Liknande verk
-
A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
av: Gill, M, et al.
Publicerad: (2016) -
Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy
av: Lee, B, et al.
Publicerad: (2019) -
111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
av: Gill, M, et al.
Publicerad: (2018) -
Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy
av: Xiang-Yu Su, et al.
Publicerad: (2014-06-01) -
Megavoltage radiosensitization of gold nanoparticles on a Glioblastoma Cancer Cell Line using a clinical platform
av: Kazmi, F, et al.
Publicerad: (2020)